COHEN & STEERS, INC.

CNS

Cohen & Steers, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments, and foundations. It manages separate client-focused equity, fixed income, multi-asset, and commodity portfolios through its subsidiaries.

About the company

Country: United StatesPrice: $71.35Market Cap: $3.7B

Investment snapshot

18%positive consensus

Scored 1d ago

Positive

BUY / PASS

Neutral / negative

3 / 10

NEUTRAL / FAIL

Median fair value

$40.48

-43.3% vs price

Models with upside

1 / 17

Positive margin of safety

Key risk

All 8 investors flag CNS's efficiency

Framework analysis

Verdict	Meaning
BUY	Positive purchase signal: the framework's buy requirements are met.
PASS	The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRAL	Neither a positive nor negative conclusion. It does not mean to hold an existing position.
FAIL	The company does not clear the framework's requirements.
Ranked	Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

Metric	Graham Defensive Value	Buffett Quality Compounder	Lynch GARP	Greenblatt Magic Formula	Piotroski F-Score	Dreman Contrarian Value	Munger Quality Focus	Pabrai Dhandho Framework	Akre Three-Legged Stool	Marks Risk-Aware Value	Ackman Activist Value	Templeton Global Bargain Hunter	Sleep Scale Economies Shared	Asness Systematic Factors	Neff Low-P/E Total Return	Schloss Asset-Value Discipline	O'Shaughnessy Systematic Factor Composite
Verdict	FAIL	FAIL	FAIL	Not ranked	FAIL	FAIL	PASS	FAIL	FAIL	FAIL	PASS	PASS	FAIL	NEUTRAL	NEUTRAL	FAIL	NEUTRAL
Score
Analysis	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…
Intrinsic Value (annual)					N/A						N/A		N/A	N/A	N/A	N/A	N/A
Margin of Safety	-163.0%	-96.2%	-76.7%	-168.4%	N/A	-67.1%	-69.7%	-88.2%	+39.8%	-75.9%	N/A	-45.7%	N/A	N/A	N/A	N/A	N/A
Financial Basis	TTM ended 2026-09-30 · Annual history · FY 2025 Latest source filing: 2026-10-30 Score computed: 2026-11-14	Annual history · FY 2025 Latest source filing: 2026-02-27 Score computed: 2026-11-14	Annual history · FY 2025 · TTM ended 2026-09-30 Latest source filing: 2026-10-30 Score computed: 2026-11-14	Annual history · FY 2025 Latest source filing: 2026-02-27 Score computed: 2026-11-14	Annual history · FY 2025 Latest source filing: 2026-02-27 Score computed: 2026-11-14	Annual history · FY 2025 · TTM ended 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-10-30 Score computed: 2026-11-14	Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-02-27 Score computed: 2026-11-14	Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-02-27 Score computed: 2026-11-14	Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-27 Score computed: 2026-11-14	Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-27 Score computed: 2026-11-14	Annual history · FY 2025 · TTM ended 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-10-30 Score computed: 2026-11-14	Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-02-27 Score computed: 2026-11-14	Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-27 Score computed: 2026-11-14	TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025 Latest source filing: 2026-10-30 Score computed: 2026-11-14	Annual history · FY 2025 Latest source filing: 2026-02-27 Score computed: 2026-11-14	Annual history · FY 2025 Latest source filing: 2026-02-27 Score computed: 2026-11-14	TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-10-30 Score computed: 2026-11-14

Where It Passes

Where It Falls Short

Efficiency0% pass✗ 11▾
All 8 investors flag CNS's efficiency
Current Ratio
✗Graham>= 2.0
ROIC (3-5 yr avg)
✗Buffett> 10%
ROIC - WACC
✗BuffettPositive (WACC = 10%)
EBIT / (NWC + Net Fixed Assets)
✗Greenblatt> 25%
Current Ratio Change YoY
✗PiotroskiIncreased YoY
Revenue / Total Assets Change YoY0.64x -> 0.63x
✗PiotroskiImproved YoY
Current Assets / Current Liabilities
✗Dreman> 1.5
Return on Invested Capital
✗Munger> 15%
ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=unavailable; FY2025: ROIC=unavailable
✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
Reinvestment Rate x ROIC
✗AkreReinvestment Rate * ROIC > 10%
ROIC (5-year)
✗SleepROIC > 12% in a majority of years
Debt & Leverage8% pass✓ 1✗ 14▾
11 of 12 flag CNS's debt & leverage — Graham, Buffett, Lynch +8 more
LT Debt vs Net Current Assets
✗GrahamLT Debt <= Net Current Assets
Debt/Equity & Interest Coverage
✗BuffettD/E < 0.5 AND Interest Coverage > 5x
Total Debt / Equity
✗Lynch< 0.33
Cash - Long-term Debt
✗LynchPositive preferred
LT Debt / Total Assets Change0.00% -> 0.00%
✓PiotroskiDecreased YoY
Current Assets / Current Liabilities
✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
Total Debt / Shareholders' Equity
✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x
Debt Levels
✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
Interest Coverage & Debt/EBITDA
✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
Total Debt / Shareholders Equity
✗Ackman<= 1.0
Negative debt-to-equity (higher means less debt)
✗AsnessTop 30% of eligible cross-section
Valuation8% pass✓ 5✗ 23▾
12 of 13 flag CNS's valuation — Graham, Lynch, Greenblatt +9 more
Net income / market capitalization+4.60%; #1810/6340 (top 28.5%)
✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
Price / 3-yr avg EPS25.1x
✗Graham<= 15x
Price-to-Book Ratio6.5x
✗Graham<= 1.5x
P/E x P/B162.40
✗Graham<= 22.5
Basic earnings-growth PEG (dividends excluded)1.77
✗Lynch< 1.0 (ideally < 0.5)
EBIT / Enterprise Value5.0%
✗Greenblatt> 10%
Earnings Yield + ROC AssessmentEY=5.0%, ROC=None
✗GreenblattBoth EY > 10% and ROC > 25%
Price / EPS24.0x
✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
Price / (CFO / Shares)N/A (negative CFPS)
✗Dreman< 8x
Price / Book Value per Share6.5x
✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
Valuation ReasonablenessP/E=24.0x, OE Yield=4.3%
✓MungerP/E < 25 or Owner Earnings Yield > 5%
P/E or FCF YieldP/E=24.0x, FCF Yield=-3.4%
✗PabraiP/E < 15 or FCF Yield > 10%
P/B or P/E vs. Historical AverageP/E=24.0x, P/B=6.5x
✗MarksP/E < 15 or P/B < 2.0
Discount to Intrinsic Value-67.1% (IV=$42.70 vs Price=$71.35)
✗Marks>= 20% below intrinsic value
Price / FCF per ShareN/A (negative FCF)
✗Ackman<= 25
Price vs. Trailing Low114% of trailing low ($62.55)
✓Templeton<= 120% of trailing low (certified split-adjusted live window)
Positive book equity / market capitalization+0.1656; #4381/6449 (top 67.9%)
✗AsnessTop 30% of eligible cross-section
Price / Diluted EPS24.0x
✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
(EPS CAGR % + Dividend Yield %) / P/E0.71
✓Neff> 0.7 (Neff's published traditional edge)
Price / Tangible Book Value per Share6.70x
✗SchlossP/TBV <= 1.00x (app cutoff)
Book Value per Share Change+203.4%
✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
Revenue / market capitalization+0.1634; #3969/5247 (top 75.6%)
✗OshaughnessyTop 10% of eligible cross-section
(Operating cash flow - capex) / market capitalization-3.45%; #2861/4519 (top 63.3%)
✗OshaughnessyTop 10% of eligible cross-section
Trailing six-month price return through the evaluation date+12.97%; #1696/6202 (top 27.3%)
✗OshaughnessyTop 10% of eligible cross-section
Valuation models10% pass✓ 1✗ 9▾
Models split on CNS at $71.35 — fair values range $26.58–$118.62
Graham fair value$27.13
✗Graham-163.0% margin vs $71.35
Buffett fair value$36.36
✗Buffett-96.2% margin vs $71.35
Lynch fair value$40.39
✗Lynch-76.7% margin vs $71.35
Greenblatt fair value$26.58
✗Greenblatt-168.4% margin vs $71.35
Dreman fair value$42.70
✗Dreman-67.1% margin vs $71.35
Munger fair value$42.04
✗Munger-69.7% margin vs $71.35
Pabrai fair value$37.92
✗Pabrai-88.2% margin vs $71.35
Akre fair value$118.62
✓Akre+39.8% margin vs $71.35
Marks fair value$40.56
✗Marks-75.9% margin vs $71.35
Templeton fair value$48.96
✗Templeton-45.7% margin vs $71.35
Verdicts23% pass✓ 3✗ 10▾
Split decision: 10 FAIL · 3 PASS · 3 NEUTRAL
Overall verdict
✗GrahamFAIL (2/9)✗BuffettFAIL (3/9)✗LynchFAIL (3/7)•GreenblattNot ranked✗PiotroskiFAIL (F-Score 2)✗DremanFAIL (4/11)✓MungerPASS (2/4)✗PabraiFAIL (0/3)✗AkreFAIL (2/6)✗MarksFAIL (2/5)✓AckmanPASS (5/9)✓TempletonPASS (4/8)✗SleepFAIL (2/6)•AsnessNEUTRAL (Not ranked)•NeffNEUTRAL (4/6)✗SchlossFAIL (3/7)•OshaughnessyNEUTRAL (Not ranked)
Cash Flow30% pass✓ 3✗ 9▾
7 of 10 flag CNS's cash flow — Lynch, Piotroski, Dreman +4 more
Free Cash Flow Proxy$157.0M
✓BuffettPositive and growing
FCF Positive and Growing$-126.4M
✗LynchPositive and growing
Operating Cash Flow$-120.4M
✗PiotroskiCFO > 0
(CFO / Total Assets) vs ROACFO/Assets=-13.74%, ROA=17.48%
✗PiotroskiCFO/Assets > ROA
Price / (CFO / Shares)N/A (negative CFPS)
✗Dreman< 8x
P/E or FCF YieldP/E=24.0x, FCF Yield=-3.4%
✗PabraiP/E < 15 or FCF Yield > 10%
FCF Positive19/20 years FCF positive
✓MarksPositive FCF in majority of recent years
(OCF - CapEx) / Market Cap-3.5%
✗Ackman>= 4%
Price / FCF per ShareN/A (negative FCF)
✗Ackman<= 25
Positive Operating Cash Flow frequency23/24 years positive
✓SleepPositive OCF in >= 70% of available years
Operating Cash Flow - Capital Expenditures$-126.4M
✗Neff> $0 (app proxy for a strong fundamental case)
(Operating cash flow - capex) / market capitalization-3.45%; #2861/4519 (top 63.3%)
✗OshaughnessyTop 10% of eligible cross-section
Profitability31% pass✓ 17✗ 18▾
11 of 16 flag CNS's profitability — Graham, Buffett, Lynch +8 more
Net income / market capitalization+4.60%; #1810/6340 (top 28.5%)
✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
Positive EPS (10 years)23/26 years positive
✗GrahamPositive EPS every year for 10 years
EPS Growth (3-yr avg, 10-yr window)
✗Graham>= 33% growth
Net Income Positive (10+ years)25/26 years positive
✗BuffettPositive every year for 10+ years
ROE (up to 5-year arithmetic mean)44.8%
✓Buffett> 15% arithmetic mean (app rule)
Operating Margin (10-yr trend)32.0% (latest)
✓BuffettStable or rising over 10 years
Free Cash Flow Proxy$157.0M
✓BuffettPositive and growing
Earnings Variance (10-yr CoV)
✗BuffettCoV < 0.3
Retained Earnings Effectiveness
✗Buffett$1 retained -> > $1 market value created
Basic earnings-growth PEG (dividends excluded)1.77
✗Lynch< 1.0 (ideally < 0.5)
3-5 Year EPS CAGR13.6%
✓Lynch15-30% (Fast Grower); > 0% to pass
ROE27.8%
✓Lynch> 15%
EBIT / Enterprise Value5.0%
✗Greenblatt> 10%
Earnings Yield + ROC AssessmentEY=5.0%, ROC=None
✗GreenblattBoth EY > 10% and ROC > 25%
Net Income / Total Assets17.48%
✓PiotroskiROA > 0
ROA Change YoY18.62% -> 17.48% (delta: -1.14%)
✗PiotroskiCurrent ROA > Prior ROA
(CFO / Total Assets) vs ROACFO/Assets=-13.74%, ROA=17.48%
✗PiotroskiCFO/Assets > ROA
Gross Margin Change YoY
✗PiotroskiImproved YoY
Pre-Tax Income / Revenue37.9%
✓Dreman>= 8%
Net Income / Shareholders' Equity27.8%
✓Dreman> 12%
Margin of SafetyP/E=24.0x, P/B=6.5x
✗PabraiP/B < 1.5 or P/E < 15
Return on Equity30.2% (3-yr avg)
✓AkreROE > 20% (3-year avg)
Discount to Intrinsic Value-67.1% (IV=$42.70 vs Price=$71.35)
✗Marks>= 20% below intrinsic value
Positive Net Income Frequency25/26 years positive
✓MarksPositive net income in >= 7 of last 10 years
Operating Income / Revenue32.4%
✓Ackman>= 15%
Net Income / Shareholders Equity27.8%
✓Ackman>= 15%
5-Year EPS CAGR13.6% CAGR over 5 years
✓Templeton> 0% (5-year EPS CAGR)
Operating Margin Trend33.6% (2023) -> 32.0% (2025)
✗TempletonNon-negative operating-margin trend over 3 years
Revenue growth vs. gross and operating margin trendrevenue up, operating margin 33.6% -> 32.0%
✗SleepRevenue rising; gross margin flat or falling; operating margin holding
Gross profit / total assets
✗AsnessTop 30% of eligible cross-section
Net income / positive book equity+27.78%; #506/5226 (top 9.7%)
✓AsnessTop 30% of eligible cross-section
Negative 5-year standard deviation of ROA-0.0972; #3439/5884 (top 58.4%)
✗AsnessTop 30% of eligible cross-section
3-5 Year Diluted EPS CAGR13.6% over 5 years
✓Neff7%-20% annualized
Positive Diluted-EPS Years10/10 years positive
✓Schloss>= 70% positive over 5-10 observed years (app rule)
Growth38% pass✓ 6✗ 7▾
5 of 8 flag CNS's growth — Graham, Lynch, Dreman +2 more
EPS Growth (3-yr avg, 10-yr window)
✗Graham>= 33% growth
Basic earnings-growth PEG (dividends excluded)1.77
✗Lynch< 1.0 (ideally < 0.5)
3-5 Year EPS CAGR13.6%
✓Lynch15-30% (Fast Grower); > 0% to pass
Inventory Growth vs Revenue GrowthN/A (no inventory)
✓LynchInventory growth < Revenue growth
EPS Growth Direction
✗DremanPositive over recent years
EPS CAGR
✗Dreman> 5% annualized
Positive Net Income Frequency25/26 years positive
✓MarksPositive net income in >= 7 of last 10 years
3yr Median Revenue Growth5.7%
✓Ackman>= 5%
Positive EPS Growth Frequency2/5 years with positive EPS growth
✗AckmanPositive EPS growth in >= 3 of last 5 years
5-Year EPS CAGR13.6% CAGR over 5 years
✓Templeton> 0% (5-year EPS CAGR)
Revenue growth vs. gross and operating margin trendrevenue up, operating margin 33.6% -> 32.0%
✗SleepRevenue rising; gross margin flat or falling; operating margin holding
5-year Revenue CAGR5.4%
✗SleepCAGR > 7%
3-5 Year Diluted EPS CAGR13.6% over 5 years
✓Neff7%-20% annualized

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Trading

SIC Sector: Security & Commodity Brokers

Size: Mid Cap($3.7B)

Revenue: $556.1M+7.5% YoY

Net Income: $153.2M+1.3% YoY

Financial Snapshot

Operating Margin32.0%

Return on Equity27.3%

Debt / Equity--

Current Ratio--

EPS (Diluted)$2.97+0.0% 1y

Buybacks (1y)$28.4M

Buybacks (2y)$49.5M

Shares Retired−0.9% / −3.4% 2y

Similar Companies

RJFRAYMOND JAMES FINANCIAL INC

$32.4B

RGLDROYAL GOLD INC

$21.7B

Shareholder Return

Fiscal 2025

Issued 0.9% of shares last year, 3.4% issued over two.

Buybacks: $28.4M
Dividends: $126.9M

What drove EPS

A buyback raises earnings per share without the company earning more. This splits each year's change into the two.

FY22

−19.5% = −19.1% + −0.5%

FY23

−25.1% = −24.6% + −0.7%

FY24

14.2% = 17.2% + −2.5%

FY25

0.0% = 1.3% + −1.3%

Earnings Fewer shares More shares

Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

Metric	TTM · 2026-09-30 2025-10-01 – 2026-09-30 Sources · derived quarter values 10-K · 2026-02-27 10-Q · 2026-05-01 10-Q · 2026-07-31 10-Q · 2026-10-30 Derived from cumulative filings: revenue, net income, operating income, ebit, pre tax income, operating cash flow, depreciation amortization, capex, dividends paid, buybacks.	Q3 FY 2026 2026-07-01 – 2026-09-30 Sources · derived quarter values 10-Q · 2026-10-30 Derived from cumulative filings: operating cash flow, capex, dividends paid, buybacks.	Q2 FY 2026 2026-04-01 – 2026-06-30 Sources · derived quarter values 10-Q · 2026-07-31 Derived from cumulative filings: operating cash flow, dividends paid, buybacks.	Q1 FY 2026 2026-01-01 – 2026-03-31 Sources 10-Q · 2026-05-01	FY 2025 Sources 10-K · 2026-02-27	FY 2024 Sources 10-K · 2025-02-21	FY 2023 Sources 10-K · 2024-02-23	FY 2022 Sources 10-K · 2023-02-24	FY 2021 Sources 10-K · 2022-02-25
Market Cap	$3.7Bcurrent	--	--	--	$3.2Best.	$4.3Best.	$3.2Best.	$3.2Best.	$3.5Best.
Revenue	$599.6M↑9%	$157.4M↑11%	$152.7M↑12%	$145.6M↑8%	$556.1M↑7%	$517.4M↑6%	$489.6M↓14%	$566.9M↓3%	$583.8M
Operating Income	$194.3M↑4%	$51.1M↑4%	$52.8M↑22%	$50.1M↑11%	$177.7M↑3%	$172.9M↑5%	$164.5M↓24%	$215.9M↓17%	$260.4M
Net Income	$168.8M↑3%	$42.2M↑1%	$49.3M↑34%	$42.4M↑7%	$153.2M↑1%	$151.3M↑17%	$129.0M↓25%	$171.0M↓19%	$211.4M
EPS (Diluted)	--	$0.81	$0.95↑32%	$0.82↑6%	$2.97	$2.97↑14%	$2.60↓25%	$3.47↓19%	$4.31
Gross Margin	—	—	—	—	—	—	—	—	—
Operating Margin	32.4%↓4%	32.4%↓6%	34.6%↑9%	34.4%↑2%	32.0%↓4%	33.4%↓1%	33.6%↓12%	38.1%↓15%	44.6%
ROE	27.8%↓7%	—	—	—	27.3%↓8%	29.6%↓13%	33.9%↓33%	50.7%↓39%	82.8%
Total Debt	--	--	--	--	--	--	--	--	--
Shareholders' Equity	$607.7M↑10%	$607.7M↑10%	$589.4M↑12%	$563.4M↑11%	$562.0M↑10%	$511.7M↑34%	$381.2M↑13%	$337.6M↑32%	$255.2M
Current Ratio	—	—	—	—	—	—	—	—	—
Debt / Equity	—	—	—	—	—	—	—	—	—
Operating Cash Flow	$37.9M↑144%	$20.9M↓62%	$67.4M↑200%	-$51.4M↑53%	-$120.4M↓225%	$96.7M↓44%	$172.0M↑179%	$61.7M↓75%	$242.9M
Free Cash Flow	--	$20.0M↓62%	--	--	-$126.4M↓249%	$85.0M↓26%	$115.0M↑100%	$57.5M↓76%	$240.2M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Trading

CNS vs Peers — Financial Grading

Revenue$556.1MBottom 25%

Net Income$153.2MMedian

ROE27.3%Top 25%

D/E—

Op. Margin32.0%Median

Curr. Ratio—

Company	Market Cap	Price	Revenue	Net Income	ROE	D/E	Op. Margin	Curr. Ratio	Graham	Buffett	Lynch	Greenblatt	Piotroski	Dreman
REALTY INCOME CORPO	$56.1B	$58.82	$5.7B	$1.1B	2.7%	0.63	16.8%	—	2/7	1/9	3/7	0/3	F-Score 6	4/10
Ventas, Inc.VTR	$47.0B	$88.92	$5.8B	$261.5M	2.1%	1.04	3.5%	—	2/7	1/9	2/7	0/3	F-Score 6	2/10
RAYMOND JAMES FINANCIAL INCRJF	$32.4B	$168.64	$15.9B	$2.1B	17.1%	0.28	—	—	3/9	3/9	3/7	1/3	F-Score 6	4/11
ROYAL GOLD INCRGLD	$21.7B	$256.89	$1.0B	$466.3M	6.5%	0.13	61.9%	3.12	4/9	2/9	4/7	0/3	F-Score 4	4/11
iShares Ethereum Trust ETFETHA	$19.4B	$44.02	—	$2.3B	—	—	—	—	—	—	—	—	—	—
KIMCO REALTY CORPKIM	$17.0B	$25.55	$2.1B	$584.7M	5.6%	0.74	36.0%	—	3/7	2/9	4/7	0/3	F-Score 7	5/10
LandBridge Co LLCLB	$5.6B	$73.15	$199.1M	$30.1M	8.9%	1.65	59.5%	4.87	2/9	3/9	2/7	0/3	F-Score 6	3/11
Digital Turbine, Inc.APPS	$927.6M	$7.61	$565.3M	$37.7M	-19.6%	1.88	6.0%	1.16	1/9	2/9	2/7	1/3	F-Score 7	0/11